Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Left Atrial Appendage (LAA) Closure Device Market, by Application
1.4.2 North America Left Atrial Appendage (LAA) Closure Device Market, by End User
1.4.3 North America Left Atrial Appendage (LAA) Closure Device Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Left Atrial Appendage (LAA) Closure Device Market by End-use
3.1 North America Hospital Market by Country
3.2 North America Ambulatory Surgery Centers Market by Country
3.3 North America Others Market by Country
Chapter 4. North America Left Atrial Appendage (LAA) Closure Device Market by Product
4.1 North America Endocardial LAA Devices Market by Country
4.2 North America Epicardial LAA Devices Market by Country
Chapter 5. North America Left Atrial Appendage (LAA) Closure Device Market by Country
5.1 US Left Atrial Appendage (LAA) Closure Device Market
5.1.1 US Left Atrial Appendage (LAA) Closure Device Market by End-use
5.1.2 US Left Atrial Appendage (LAA) Closure Device Market by Product
5.2 Canada Left Atrial Appendage (LAA) Closure Device Market
5.2.1 Canada Left Atrial Appendage (LAA) Closure Device Market by End-use
5.2.2 Canada Left Atrial Appendage (LAA) Closure Device Market by Product
5.3 Mexico Left Atrial Appendage (LAA) Closure Device Market
5.3.1 Mexico Left Atrial Appendage (LAA) Closure Device Market by End-use
5.3.2 Mexico Left Atrial Appendage (LAA) Closure Device Market by Product
5.4 Rest of North America Left Atrial Appendage (LAA) Closure Device Market
5.4.1 Rest of North America Left Atrial Appendage (LAA) Closure Device Market by End-use
5.4.2 Rest of North America Left Atrial Appendage (LAA) Closure Device Market by Product
Chapter 6. Company Profiles
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 Recent strategies and developments:
6.1.5.1 Acquisition and Mergers:
6.1.5.2 Approvals and Trials:
6.1.6 SWOT Analysis
6.2 AtriCure, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Acquisition and Mergers:
6.3 Abbott Laboratories
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expenses
6.3.5 Recent strategies and developments:
6.3.5.1 Approvals and Trials:
6.3.6 SWOT Analysis
6.4 Johnson & Johnson (Johnson & Johnson Services, Inc.)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 SWOT Analysis
6.5 Occlutech Holding AG
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.6 LifeTech Scientific Corporation
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Cardia, Inc.
6.7.1 Company Overview
6.8 Lepu Medical Technology Co., Ltd
6.8.1 Company Overview
Unique Offerings 